LABORATORY SPECIALISTS OF MICHIGAN, LLC
NPI 1861972457
Clinical Medical Laboratory in Dearborn, MI

NPI Status: Active since August 14, 2018

Contact Information

13530 MICHIGAN AVE STE 240
DEARBORN, MI
ZIP 48126
Phone: (954) 818-1533

Get Directions Write a Review

  • Organization
  • Clinical Medical Laboratory
  • Accepts Insurance
  • CLIA Number: 23D2153137
  • CLIA Cert. Type: Independent
  • CLIA Exp. Date: 07-02-2027

About LABORATORY SPECIALISTS OF MICHIGAN, LLC

This page provides the complete NPI Profile along with additional information for Laboratory Specialists Of Michigan, Llc, a provider established in Dearborn, Michigan operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1861972457 assigned on August 2018. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 8 years ago. The authorized official of this NPI record is Arthur Schnur (Managing Member)

NPI
1861972457
Provider Name
LABORATORY SPECIALISTS OF MICHIGAN, LLC
Entity Type
Organization
Location Address
13530 MICHIGAN AVE STE 240 DEARBORN, MI 48126
Location Phone
(954) 818-1533
Mailing Address
13530 MICHIGAN AVE STE 240 DEARBORN, MI 48126
Mailing Phone
(954) 818-1533
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
08-14-2018
Last Update Date
08-17-2018
Code Navigator

Establishments like Laboratory Specialists Of Michigan, Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.

Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinical Medical Laboratory

Taxonomy Code
291U00000X
Type
Laboratories
Taxonomy Description
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.

Insurance Plans Accepted

According to publicly available information the provider might be accepting the following health plans from these health insurance companies:

  • Blue Cross� Premier PPO Bronze Extra - PPO
  • Blue Cross� Premier PPO Bronze Saver HSA - PPO
  • Blue Cross� Premier PPO Bronze Secure - PPO
  • Blue Cross� Premier PPO Gold - PPO
  • Blue Cross� Premier PPO Gold Extra - PPO
  • Blue Cross� Premier PPO Silver - PPO
  • Blue Cross� Premier PPO Silver Extra - PPO
  • Blue Cross� Premier PPO Silver Saver HSA - PPO
  • Blue Cross� Premier PPO Value - PPO
  • MHP Bronze - HMO
  • MHP Bronze Saver (Expanded) - HMO
  • MHP Expanded Bronze Standard - HMO
  • MHP Gold - HMO
  • MHP Gold Standard - HMO
  • MHP Silver Exchange - HMO
  • MHP Silver Exchange Rewards - HMO
  • MHP Silver Standard - HMO
  • MHP Young Adult/Catastrophic - HMO

*Please verify directly with this provider to make sure your insurance plan is currently accepted.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

ARTHUR SCHNUR

Authorized Official Title
MANAGING MEMBER
Authorized Official Phone
(954) 818-1533

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus

This test identifies if you have COVID-19, influenza A or B, or respiratory syncytial virus. It uses a multiplex amplified probe technique, which amplifies and detects specific genetic material of the viruses, helping in accurate diagnosis.

This service was performed 31 times for 30 patients

Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique

This test checks for the presence of Chlamydia pneumoniae, a bacterium that can cause respiratory infections. It uses an amplified probe technique, which magnifies the bacterium's genetic material for easier detection. It's a standard, non-invasive procedure.

This service was performed 32 times for 30 patients

Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique

This test identifies the presence of an enterovirus, a type of virus that primarily targets the digestive system. It uses a method called the amplified probe technique to boost the detection of the virus's genetic material, or nucleic acid.

This service was performed 32 times for 30 patients

Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique

This test checks for Mycoplasma pneumoniae, a bacteria that can cause lung infection. It uses a method called amplified probe technique, which identifies the bacteria's genetic material. This helps in diagnosing the infection accurately.

This service was performed 32 times for 30 patients

Detection test by nucleic acid for organism, amplified probe technique

A nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.

This service was performed 365 times for 35 patients

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test is a detailed analysis used to identify specific drugs in your system. It uses advanced techniques, such as gc/ms and lc/ms, to detect and distinguish between different drugs, even those with similar structures.

This service was performed 520 times for 304 patients

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test identifies specific drugs in your system. Advanced methods like GC/MS (Gas Chromatography/Mass Spectrometry) and LC/MS (Liquid Chromatography/Mass Spectrometry) are used. These can distinguish between similar drugs, providing precise results.

This service was performed 14 times for 14 patients

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test identifies specific drugs in your system. It uses advanced methods like gc/ms and lc/ms, which can distinguish between different types of drugs but not necessarily their 3D forms. This test offers detailed results to support your healthcare decisions.

This service was performed 230 times for 136 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within

This is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.

This service was performed 185 times for 155 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r

This is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.

This service was performed 185 times for 155 patients

Testing for presence of drug, by chemistry analyzers

Chemistry analyzers are used to detect the presence of drugs in your system. This test involves taking a small sample of your blood or urine. The sample is then analyzed for specific substances. The results help in understanding your health condition better.

This service was performed 240 times for 127 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
23D2153137
Facility Type
Independent
Certificate Effective Date
July 03, 2025
Certificate Expiration Date
July 02, 2027
Laboratory Director
SURAJ SAKSENA
Certificate Type
Certificate of Accreditation
Certificate Type Description
This is a CLIA certificate is issued to Laboratory Specialists Of Michigan, Llc on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.

Reviews for LABORATORY SPECIALISTS OF MICHIGAN, LLC

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI NPI Number Validation

How NPI Validation Works

The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.

To verify the NPI 1861972457, we treat the final digit (7) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 63. The final step is to find the difference between that total and the next multiple of ten (70 - 63 = 7).

Digit-by-digit view

Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.

Pos 1
1
Doubled → 2
Pos 2
8
Unchanged
Pos 3
6
Doubled → 12 → 1 + 2
Pos 4
1
Unchanged
Pos 5
9
Doubled → 18 → 1 + 8
Pos 6
7
Unchanged
Pos 7
2
Doubled → 4
Pos 8
4
Unchanged
Pos 9
5
Doubled → 10 → 1 + 0
Check
7
Target digit
Regular digit Doubled digit Check digit

Step 1: Double every other digit from the right

Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.

1 → 2 6 → 12 → 3 9 → 18 → 9 2 → 4 5 → 10 → 1

Step 2: Add all digits plus the NPI constant

Add the transformed values, the unchanged digits, and the constant 24.

2 + 8 + 1 + 2 + 1 + 1 + 8 + 7 + 4 + 4 + 1 + 0 + 24 = 63

Step 3: Find the amount needed to reach the next multiple of 10

The next multiple of ten after 63 is 70. The difference is the calculated check digit.

70 - 63 = 7
This NPI is valid
The calculated check digit is 7, which matches the last digit of 1861972457.

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1861972457, enumerated as an "organization" on August 14, 2018.

The provider is located at 13530 MICHIGAN AVE STE 240 DEARBORN, MI 48126 and the phone number is (954) 818-1533.

Clinical Medical Laboratory with taxonomy code 291U00000X.

The provider might be accepting Accepts: Blue Cross Blue Shield of Michigan Mutual. Please consult your insurance carrier or call the provider to verify.